Julie Phillips
Chief Executive Officer at BioDiem Ltd.
Profile
Julie Phillips is currently the Chief Executive Officer & Executive Director at BioDiem Ltd., the Director at CRC for Asthma & Airways, the Director at Subtech International Pty Ltd., and the Managing Director & Director at Opal Biosciences Ltd.
She previously served as the Chairman at AusBiotech Ltd.
from 2014 to 2020.
Julie Phillips active positions
Companies | Position | Start |
---|---|---|
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | Chief Executive Officer | 2009-07-13 |
CRC for Asthma & Airways
CRC for Asthma & Airways Medical SpecialtiesHealth Technology The CRC for Asthma & Airways discovers and develops novel therapeutics and diagnostics for people with asthma. The private company is based in Camperdown, Australia. | Director/Board Member | - |
Subtech International Pty Ltd. | Director/Board Member | - |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Chief Executive Officer | - |
Former positions of Julie Phillips
Companies | Position | End |
---|---|---|
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Chairman | 2019-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | Health Technology |
CRC for Asthma & Airways
CRC for Asthma & Airways Medical SpecialtiesHealth Technology The CRC for Asthma & Airways discovers and develops novel therapeutics and diagnostics for people with asthma. The private company is based in Camperdown, Australia. | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
Subtech International Pty Ltd. | |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Health Technology |
- Stock Market
- Insiders
- Julie Phillips